Response of MHC Class-1 Antigen on Rat Glioma Cells to Cytokines
Overview
Authors
Affiliations
Background: Enhanced MHC class-1 expression has potentially been correlated with the increased susceptibility of tumor cells to a T cell-mediated immune response. We examined the immunomodulatory effects of some cytokines on MHC class-1 expression in rat glioma cell lines.
Materials And Methods: Using three rat glioma cell lines (RG2, C6, 9L), the immunomodulatory effects of cytokines (rhIL-2, rmIL-4, rmGM-CSF, rrIFN-gamma) on the expression of MHC class-1 antigen were evaluated using immunohistochemical and flow cytometric analyses.
Results: Varying baseline levels of MHC class-1 antigen were confirmed in each glioma cell line. Stimulation with rrIFN-gamma consistently increased the expression of MHC-1 antigen in all three of the rat glioma cell lines. On the other hand, MHC class-1 expression was not affected by stimulation with rhIL-2, rmIL-4 or rmGM-CSF, even in combination.
Conclusions: rrIFN-gamma can upregulate MHC class-1 expression in rat glioma cells. Our data suggest that rrIFN-gamma may be able to exert antitumor activity against gliomas in vivo.
The detection of CMV pp65 and IE1 in glioblastoma multiforme.
Lucas K, Bao L, Bruggeman R, Dunham K, Specht C J Neurooncol. 2010; 103(2):231-8.
PMID: 20820869 DOI: 10.1007/s11060-010-0383-6.
Detailed characterization of the mouse glioma 261 tumor model for experimental glioblastoma therapy.
Szatmari T, Lumniczky K, Desaknai S, Trajcevski S, Hidvegi E, Hamada H Cancer Sci. 2006; 97(6):546-53.
PMID: 16734735 PMC: 11159227. DOI: 10.1111/j.1349-7006.2006.00208.x.
Use of replication-competent retroviral vectors in an immunocompetent intracranial glioma model.
Wang W, Tai C, Kershaw A, Solly S, Klatzmann D, Kasahara N Neurosurg Focus. 2006; 20(4):E25.
PMID: 16709031 PMC: 8295718. DOI: 10.3171/foc.2006.20.4.1.